Brook Byers is a venture capital investor who has been active since 1972 and served as a Partner at Kleiner Perkins. See sector focus and contact routes.
Brook Byers is a venture capital investor who has been active since 1972 and served as a Partner at Kleiner Perkins, where he formed the profession’s first life sciences practice group in 1984. He led the firm to become a premier investor in life sciences, healthcare, and biotechnology, and helped incubate four biotechnology companies that later became public with an aggregate market value exceeding $8 billion. His investment thesis targets Consumer Health, BioTech, Health IT, Health & Hospital Services, and Digital Health companies at Series A and Series B stages. Typical check sizes range from $100,000 to $25 million, with Byers directing investments toward more mature healthcare innovators. Notable portfolio companies include Arsenal Bio, Octave Bio, Newsela, and Verana Health, all of which he currently serves on the board of. Byers is also a founder of TechNet and has held leadership roles at Stanford University and Georgia Tech, reflecting his distinctive focus on bridging technology and life sciences.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Menlo Park.
Investors like Brook Byers · Full investor directory · Investor access · Company funding database
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide